As of 2026-09-16, the Relative Valuation of Relay Therapeutics Inc (RLAY) is (35.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.97 USD, the upside of Relay Therapeutics Inc based on Relative Valuation is -286.4%.
The range of the Relative Valuation is (30.92) - (39.41) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.2x - 29.7x | 26.4x |
| Forward P/E multiples | 23.3x - 30.4x | 26.8x |
| Fair Price | (30.92) - (39.41) | (35.36) |
| Upside | -263.0% - -307.8% | -286.4% |
| Date | P/E |
| 2026-09-15 | -14.30 |
| 2026-09-14 | -14.36 |
| 2026-09-11 | -14.22 |
| 2026-09-10 | -14.24 |
| 2026-09-09 | -14.06 |
| 2026-09-08 | -14.40 |
| 2026-09-04 | -14.35 |
| 2026-09-03 | -14.33 |
| 2026-09-02 | -13.95 |
| 2026-09-01 | -13.93 |
| 2026-08-31 | -13.85 |
| 2026-08-28 | -14.15 |
| 2026-08-27 | -14.64 |
| 2026-08-26 | -14.67 |
| 2026-08-25 | -15.50 |
| 2026-08-24 | -14.89 |
| 2026-08-21 | -14.65 |
| 2026-08-20 | -14.85 |
| 2026-08-19 | -15.63 |
| 2026-08-18 | -15.53 |
| 2026-08-17 | -15.58 |
| 2026-08-14 | -14.97 |
| 2026-08-13 | -15.02 |
| 2026-08-12 | -15.12 |
| 2026-08-11 | -15.06 |
| 2026-08-10 | -15.03 |
| 2026-08-07 | -14.90 |
| 2026-08-06 | -14.88 |
| 2026-08-05 | -14.84 |
| 2026-08-04 | -14.73 |
| 2026-08-03 | -14.15 |
| 2026-07-31 | -14.19 |
| 2026-07-30 | -14.66 |
| 2026-07-29 | -13.84 |
| 2026-07-28 | -13.78 |
| 2026-07-27 | -14.05 |
| 2026-07-24 | -13.90 |
| 2026-07-23 | -14.39 |
| 2026-07-22 | -14.52 |
| 2026-07-21 | -14.54 |
| 2026-07-20 | -14.45 |
| 2026-07-17 | -15.00 |
| 2026-07-16 | -14.60 |
| 2026-07-15 | -14.70 |
| 2026-07-14 | -14.38 |
| 2026-07-13 | -14.12 |
| 2026-07-10 | -15.08 |
| 2026-07-09 | -15.64 |
| 2026-07-08 | -14.79 |
| 2026-07-07 | -14.88 |